ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives

Bioorg Med Chem. 2004 May 15;12(10):2553-70. doi: 10.1016/j.bmc.2004.03.028.

Abstract

A series of biphenyl carbaldehyde oximes (6) was prepared and shown to have significant selectivity for the estrogen receptor-beta (ERbeta). The exploitation of the oxime moiety as a hydrogen bond donating group, which mimicked the C-ring of genistein makes these compounds unique. Molecular modeling studies showed the oxime moiety hydrogen bonding to the histidine residue, which was supported by the structure-activity relationships. The most potent compounds in this study had IC50 values in a radioligand binding assay of between 8-35 nM. Among the most selective compounds were 6i and 6s (49- and 31-fold ERbeta selective, respectively).

MeSH terms

  • Binding, Competitive
  • Biphenyl Compounds / chemical synthesis
  • Biphenyl Compounds / chemistry
  • Biphenyl Compounds / pharmacology
  • Cell Line, Tumor
  • Estrogen Receptor alpha / agonists
  • Estrogen Receptor alpha / antagonists & inhibitors
  • Estrogen Receptor beta / agonists*
  • Estrogen Receptor beta / antagonists & inhibitors*
  • Gene Expression Regulation / genetics
  • Humans
  • Keratins / genetics
  • Ligands
  • Molecular Conformation
  • Molecular Structure
  • Oximes / chemical synthesis*
  • Oximes / chemistry
  • Oximes / pharmacology*
  • Quantitative Structure-Activity Relationship
  • RNA, Messenger / analysis
  • Radioligand Assay

Substances

  • 4-hydroxy-biphenyl-carbaldehyde oxime
  • Biphenyl Compounds
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Ligands
  • Oximes
  • RNA, Messenger
  • Keratins